<DOC>
	<DOCNO>NCT00000554</DOCNO>
	<brief_summary>To evaluate innovative diagnostic method improve diagnostic reliability cardiovascular test evaluation ischemic heart disease woman . Innovative approach propose include physiologic functional measurement impaired metabolism , perfusion , endothelial function well assessment epicardial coronary artery angiography . Other objective include develop safe , accurate , cost effective diagnostic approach evaluate woman suspect ischemic heart disease , determine frequency myocardial ischemia absence significant epicardial coronary stenosis , well frequency non-ischemic non-cardiac chest pain . A key aspect WISE study determine whether evidence myocardial ischemia occur absence obstructive coronary disease .</brief_summary>
	<brief_title>Women 's Ischemia Syndrome Evaluation ( WISE )</brief_title>
	<detailed_description>BACKGROUND : Cardiovascular disease exact heavy burden health woman . Ischemic heart disease claim live nearly 250,000 woman United States year . Recognition ischemic heart disease woman major challenge primary care physician . Diagnosis ischemic heart disease require recognition clinical symptom chest pain , event myocardial infarction , evaluate physician confirm diagnosis objective test . Unfortunately , symptom recognition diagnostic test confuse rather confirm diagnosis myocardial ischemia woman . Chest pain syndromes suspicious myocardial ischemia common woman . Noninvasive diagnostic method often confirm diagnosis ass disease severity men less reliable woman . This lack objective data support diagnosis chronic acute myocardial ischemia may influence physician 's decision evaluate woman risk . With precision diagnosis , effort optimize therapy hamper . The detection epicardial coronary atherosclerosis major objective clinical cardiology . The utility approach well establish . However , although presence atherosclerosis sufficient cause myocardial ischemia , whether significant ischemia risk ischemia exist absence angiographic epicardial stenosis , know may important woman . Recent progress understand pathophysiology myocardial ischemia provide complex causal pathway heretofore notion fix atherosclerotic obstruction passive conduit . Diseased artery may appear angiographically normal well artery fix obstruction respond vasomotor influence detrimental amount vasoconstriction . The endothelium generate vasoactive anticoagulant factor important mediator thrombosis . Cycling hormone may influence complex interaction . Methods rely solely fix obstruction epicardial artery possible may useful recognize early atherosclerosis , example , endothelial dysfunction place patient risk untoward coronary event . The concept study develop Cardiology Advisory Committee collaboration staff approve May 1993 National Heart , Lung , Blood Advisory Council . The Request Proposals release April 1994 . DESIGN NARRATIVE : The Women 's Ischemia Syndrome Evaluation ( WISE ) four center study design evaluate ischemic heart disease pathophysiology woman . WISE test focus three area : 1 ) optimize symptom evaluation diagnostic test ischemic heart disease ; 2 ) explore mechanism symptom evidence myocardial ischemia absence epicardial coronary artery disease ; 3 ) evaluate influence reproductive hormone symptom diagnostic test response . The WISE core data base include demographic clinical data , symptom psychosocial variable , coronary angiography ventriculography data , blood lipoprotein/homocysteine/lipid peroxidation/genetic/hormone/ phytoestrogen analysis , brachial artery reactivity testing , resting/ambulatory electrocardiographic ( ECG ) monitoring . Site specific complementary method include physiologic functional cardiovascular assessment myocardial perfusion metabolism , ventriculography , endothelial vascular function coronary angiography . Women follow least one year assess clinical event symptom status . In Phase I ( 1996-7 ) , pilot phase , 256 woman study . Phase II complete enrol 1008 woman study . The WISE study define contemporary comprehensive state-of-the-art diagnostic test evaluate woman suspect ischemic heart disease , explore sex specific ischemic heart disease pathophysiology . The study renew April , 2005 extend patient follow-up minimum five year . Dr. Kelsey ( U01HL64829 ) Data Coordinating Center University Pittsburgh continue follow-up , develop sex-specific incremental outcome model evaluate prognostic value female reproductive variable , ass cost effectiveness WISE test technique , continue data analysis . Dr. Reis ( U01HL64914 ) study immunologic basis coronary disease woman , focus role inflammation cytokine production . He measure several cytokine cytokine-related protein genotype approximately 900 store sample WISE participant . Dr. Pepine ( U01HL64924 ) study renin angiotensin system coronary microvascular dysfunction , focus whether polymorphisms renin-angiotensin/kallikrein-kinin system beta-adrenergic receptor polymorphisms associate abnormal coronary microvascular function determine coronary flow reserve measurement .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>Women age 18 suspected ischemic heart disease .</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>